View in EDS PDF Full Text

Lack of Benefit of Intravenous Synthetic Human Secretin in the Treatment of Autism.

Saved in:
Bibliographic Details
Title: Lack of Benefit of Intravenous Synthetic Human Secretin in the Treatment of Autism.
Authors: Molloy CA (AUTHOR), Manning-Courtney P (AUTHOR), Swayne S (AUTHOR), Bean J (AUTHOR), Brown JM (AUTHOR), Murray DS (AUTHOR), Kinsman AM (AUTHOR), Brasington M (AUTHOR), Ulrich CD II (AUTHOR)
Source: Journal of Autism & Developmental Disorders. Dec2002, Vol. 32 Issue 6, p545-545. 1p.
Abstract: The objective of this study was to determine if an intravenous infusion of synthetic human secretin improves language and behavioral symptoms in children with autism. Forty-two children with the diagnosis of autism were randomized to one of two groups in this double-blind cross-over trial. One group received 2 IU/kg of intravenous synthetic human secretin at the first visit, followed by an equal volume of intravenous saline placebo at week 6. The other group received treatments in the reverse order. All children were evaluated at weeks 1, 3, 6, 9, and 12 with standardized assessments of language, behavior, and autism symptomatology. There were no significant differences in the mean scores on any measure of language, behavior, or autism symptom severity after treatment with secretin compared to treatment with placebo. The results of this study do not support secretin as a treatment for autism. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Autism & Developmental Disorders is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 106080159
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lack of Benefit of Intravenous Synthetic Human Secretin in the Treatment of Autism.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Molloy+CA%22">Molloy CA</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Manning-Courtney+P%22">Manning-Courtney P</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Swayne+S%22">Swayne S</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bean+J%22">Bean J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brown+JM%22">Brown JM</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Murray+DS%22">Murray DS</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kinsman+AM%22">Kinsman AM</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brasington+M%22">Brasington M</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ulrich+CD+II%22">Ulrich CD II</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Autism+%26+Developmental+Disorders%22">Journal of Autism & Developmental Disorders</searchLink>. Dec2002, Vol. 32 Issue 6, p545-545. 1p.
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The objective of this study was to determine if an intravenous infusion of synthetic human secretin improves language and behavioral symptoms in children with autism. Forty-two children with the diagnosis of autism were randomized to one of two groups in this double-blind cross-over trial. One group received 2 IU/kg of intravenous synthetic human secretin at the first visit, followed by an equal volume of intravenous saline placebo at week 6. The other group received treatments in the reverse order. All children were evaluated at weeks 1, 3, 6, 9, and 12 with standardized assessments of language, behavior, and autism symptomatology. There were no significant differences in the mean scores on any measure of language, behavior, or autism symptom severity after treatment with secretin compared to treatment with placebo. The results of this study do not support secretin as a treatment for autism. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Journal of Autism & Developmental Disorders is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=106080159
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1023/a:1021202930206
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: 545
    Titles:
      – TitleFull: Lack of Benefit of Intravenous Synthetic Human Secretin in the Treatment of Autism.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Molloy CA
      – PersonEntity:
          Name:
            NameFull: Manning-Courtney P
      – PersonEntity:
          Name:
            NameFull: Swayne S
      – PersonEntity:
          Name:
            NameFull: Bean J
      – PersonEntity:
          Name:
            NameFull: Brown JM
      – PersonEntity:
          Name:
            NameFull: Murray DS
      – PersonEntity:
          Name:
            NameFull: Kinsman AM
      – PersonEntity:
          Name:
            NameFull: Brasington M
      – PersonEntity:
          Name:
            NameFull: Ulrich CD II
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2002
              Type: published
              Y: 2002
          Identifiers:
            – Type: issn-print
              Value: 01623257
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Journal of Autism & Developmental Disorders
              Type: main
ResultId 1